CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
repeated 3D gait-analysisother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06355869
NCT06355869N/ACompleted

Repeatability of Gait of Children With Spastic Cerebral Palsy in Different Walking Conditions

Universitaire Ziekenhuizen KU Leuven·observational·Posted Apr 10, 2024·Updated Apr 15, 2024

In Brief

An observational study evaluating repeated 3D gait-analysis for Spastic Cerebral Palsy. Completed, enrolled 10 participants across 1 site.

Detailed Summary

Three-dimensional gait analysis (3DGA) is the 'gold standard' for measurement and description of gait. Gait variability can arise from intrinsic and extrinsic factors and may vary between walking conditions. This study aimed to define the inter-trial (intrinsic) and inter-session (extrinsic) repeatability in gait analysis data of children with CP who were walking in four conditions, namely barefoot or with ankle-foot orthosis, and overground or treadmill.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesBelgium
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 10, 2024
Enrollment StartAug 17, 2021
Primary CompletionMay 31, 2023
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 2.2 years ago

Interventions

repeated 3D gait-analysisother

An observational 3D gait-analysis was performed with a period of 1-14 days is foreseen between the two measurements.